Abstracts tagged "Autoantibodies and systemic sclerosis"

Abstract Number: 802 • 2018 ACR/ARHP Annual Meeting
Prognostic Significance of Bicaudal D2 Antibodies in Sistemic Sclerosis (SSc) Patients
Giulia Segatto¹, Chiara Bellocchi², Gaia Montanelli¹, Silvia Casas³, Karl Norvell⁴, Michelle Amino³, Fabrece Roup⁴, Michael Mahler⁴ and Lorenzo Beretta², ¹Scleroderma Unit, Referral Center for Systemic Autoimmune Diseases, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico di Milano, Milano, Italy, ²Scleroderma Unit, Referral Center for Systemic Autoimmune Diseases, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico di Milano, Milan, Italy, ³Inova Diagnostics, San Diego, CA, ⁴Research and Development, Inova Diagnostics, San Diego, CA
Background/Purpose: Antibodies (Ab) toward Bicaudal D homolog 2 (BlCD2) can be found in 25% of Systemic Sclerosis (SSc) sera, mostly in association with anti-centromere (ACA)…
Abstract Number: 747 • 2017 ACR/ARHP Annual Meeting
Autoantibodies to Rpp25 (Th/To) Are Specific Markers for Systemic Sclerosis and Are Associated with Limited Cutaneous Disease and Young Age at Disease Onset
Boyang Zheng¹, Martial Koenig², Marychel Tiongson³, Andrea Seaman³, Danilo Villalta⁴, Gabriella Morozzi⁵, Nicola Bizzaro⁶, Gabriella Pucci⁷, Michaelin Richards³ and Michael Mahler³, ¹Division of Internal Medicine, Centre Hospitalier de l'Université de Montréal (CHUM), Montreal, QC, Canada, ²Internal Medicine, Hôpital Notre-Dame du CHUM, Montréal, QC, Canada, ³Research and Development, Inova Diagnostics, San Diego, CA, ⁴Allergologia e Immunologia Clinica, AO S. Maria degli Angeli, Pordenone, Pordenone, Italy, ⁵Chirurgiche e Neuroscienze, Sezione di Reumatologia, Università di Siena, Dipartimento Scienze Mediche, Siena, Italy, ⁶Ospedale San Antonio, Tolmezzo, Italy, ⁷Chirurgiche e Neuroscienze, Sezione di Reumatologia, Università di Siena, Siena, Italy
Autoantibodies to Rpp25 (Th/To) are specific markers for systemic sclerosis and are associated with limited cutaneous disease and young age at disease onset[MM1] Boyang Zheng4, Martial…
Abstract Number: 1712 • 2014 ACR/ARHP Annual Meeting
Monocytic Angiotensin and Endothelin Receptor Imbalance Determines Secretion of the Profibrotic Chemokine Ligand CCL18
Judith Rademacher¹, Jeannine Guenther², Angela Kill³, Elise Siegert⁴ and Gabriela Riemekasten⁵, ¹Charité University Hospital and German Rheumatism Research Centre, a Leibniz Institute, Berlin, Germany, 10117 Berlin, Germany, ²Rheumatology/Clinical Immunology, Charité University Hospital and German Rheumatism Research Centre, a Leibniz Institute, Berlin, Germany, Berlin, Germany, ³Rheumatology and clinical Immunology, Charité University Hospital, German Rheumatology Research Center, a Leibniz Institute, Berlin, Germany, ⁴Rheumatology and Clinical Immunology, Charité – University Hospital, Berlin, Germany, ⁵Charité University Hospital and German Rheumatism Research Centre, a Leibniz Institute, Berlin, Germany
Background/Purpose Circulating monocytes are progrenitor of extra-cellular matrix producing cells involved in fibrosis and show highest expression of angiotensin II (ATR) and endothelin receptors (ETR)…
Abstract Number: 1748 • 2013 ACR/ARHP Annual Meeting
Autoantibodies To RuvBL1 and RuvBL2: A Novel Systemic Sclerosis-Related Antibody Associated With Diffuse Cutaneous and Skeletal Muscle Involvement
Kenzo Kaji¹, Noreen Fertig², Thomas A. Medsger Jr.³, Takashi Sathoh⁴, Kana Hoshino⁴, Yasuhito Hamaguchi¹, Minoru Hasegawa⁵, Mary Lucas⁶, Andrew Schnure⁶, Fumihide Ogawa⁷, Shinichi Sato⁸, Kazuhiko Takehara⁹, Manabu Fujimoto⁵ and Masataka Kuwana⁴, ¹Department of Dermatology, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Japan, ²University of Pittsburgh, Pittsburgh, PA, ³Medicine/Rheumatology, University of Pittsburgh, Pittsburgh, PA, ⁴Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan, ⁵Dermatology, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Japan, ⁶Division of Rheumatology, University of Pittsburgh, Pittsburgh, PA, ⁷Dermatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan, ⁸Department of Dermatology, Faculty of Medicine, University of Tokyo, Tokyo, Japan, ⁹Dermatology, Kanazawa University, Kanazawa, Japan
Background/Purpose: Detection of serum autoantibodies is useful in diagnosis, disease subgrouping, and prediction of subsequent organ involvement and prognosis in patients with systemic sclerosis (SSc).…
Abstract Number: 705 • 2013 ACR/ARHP Annual Meeting
Treatment With Rituximab Reduces Activation Of Scleroderma Dermal Fibroblasts
Paolo Fraticelli¹, Salvatore De Vita², Nicoletta Franzolini³, Silvia Svegliati⁴, Cecilia Tonnini⁴, Barbara Gabrielli⁵, Cathryn Anne Scott⁶, Giovanni Pomponio⁷, Gianluca Moroncini⁴ and Armando Gabrielli⁴, ¹Istituto di Clinica Medica, Università Politecnica delle Marche, Ancona, Italy, ²Rheumatology, DSMB, University Hospital Santa Maria della Misericordia, Udine, Italy, ³Presidio Ospedaliero di San Daniele del Friuli, ASS 4 “Medio Friuli, Udine, Italy, ⁴Scienze Cliniche e Molecolari, Università Politecnica delle Marche, Ancona, Italy, ⁵Università Politecnica delle Marche, Ancona, Italy, ⁶Department of Medical and Biological Sciences, Università degli studi di Udine ·, Udine, Italy, ⁷Medicina Interna, Ospedali Riuniti, Ancona, Italy
Background/Purpose: There is evidence that B lymphocytes play a role in the pathogenesis of systemic sclerosis (scleroderma). Stimulatory autoantibodies targeting PDGF receptor and activating normal…
Abstract Number: 714 • 2012 ACR/ARHP Annual Meeting
Line Blot Assay, a Screening Test for Autoantibodies in Systemic Sclerosis (SSc)
Kae Takagi¹, Yasushi Kawaguchi¹, Sayuri Kataoka¹, Yuko Ota², Yuko Okamoto¹, Masanori Hanaoka¹, Hisae Ichida¹, Takahisa Gono¹, Yasuhiro Katsumata¹ and Hisashi Yamanaka¹, ¹Institute of Rheumatology, Tokyo Women's Medical University, Tokyo, Japan, ²Institute of Rheumatology,Tokyo Women's Medical University, Tokyo, Japan
Background/Purpose: Detection of auto-antibody is informative for diagnosis of SSc. Line blot assay (LBA) provides a quantitative in vitro assay for detecting human IgG class…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].